Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Virology

• Publication date

  2003-07-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0042-6822(03)00115-6PMID 12842618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modelling the structure of the fusion protein from human respiratory syncytial virus.

  2002cited by this paper
• Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin.

  2001cited by this paper
• Functional Analysis of Recombinant Respiratory Syncytial Virus Deletion Mutants Lacking the Small Hydrophobic and/or Attachment Glycoprotein Gene

  2001cited by this paper
• Proteolytic Activation of Respiratory Syncytial Virus Fusion Protein

  2001cited by this paper
• Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion

  2001cited by this paper
• The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion.

  2001cited by this paper
• Molecular epidemiology of respiratory syncytial virus

  2001cited by this paper
• The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core.

  2000cited by this paper
• Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection

  2000cited by this paper
• Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex.

  2000cited by this paper
• The Core of the Respiratory Syncytial Virus Fusion Protein Is a Trimeric Coiled Coil

  2000cited by this paper
• Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans.

  2000cited by this paper
• Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies.

  2000cited by this paper
• Structural characterization of the human respiratory syncytial virus fusion protein core.

  2000cited by this paper
• Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.

  1999cited by this paper
• Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket.

  1999cited by this paper
• Conformational studies of a short linear peptide corresponding to a major conserved neutralizing epitope of human respiratory syncytial virus fusion glycoprotein.

  1998cited by this paper
• CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats.

  1998cited by this paper
• Antigenic Structure of Human Respiratory Syncytial Virus Fusion Glycoprotein

  1998cited by this paper
• SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

  1997cited by this paper
• VERIFY3D: assessment of protein models with three-dimensional profiles.

  1997cited by this paper
• Codon usage limitation in the expression of HIV-1 envelope glycoprotein.

  1996cited by this paper
• A point mutation in the F1 subunit of human respiratory syncytial virus fusion glycoprotein blocks its cell surface transport at an early stage of the exocytic pathway.

  1996cited by this paper
• Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion.

  1994cited by this paper
• PHD - an automatic mail server for protein secondary structure prediction

  1994cited by this paper
• MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents.

  1994cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• Assessment of protein models with three-dimensional profiles

  1992cited by this paper
• Sequence analysis of the gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in paramyxovirus fusion glycoproteins.

  1992cited by this paper
• Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.

  1991cited by this paper
• Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells.

  1991cited by this paper
• Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins.

  1990cited by this paper
• Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virus.

  1987cited by this paper
• Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

  1986cited by this paper
• The thermal decomposition of uranyl formate and the preparation of ammonium uranyl formate, (NH4)2UO2(COOH)4

  1976cited by this paper
• The Tecumseh study of respiratory illness. 3. Incidence and periodicity of respiratory syncytial virus and Mycoplasma pneumoniae infections.

  1971cited by this paper

• Single-molecule localisation microscopy approaches reveal envelope glycoprotein clusters in single-enveloped viruses: a potential functional role?

  2025cites this paper
• Respiratory Syncytial Virus Prevention in the Adult Population: State of the Art

  2025cites this paper
• Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein

  2024cites this paper
• Improved RSV PreF protein vaccine quality and stability by elucidation of supercooling-induced aggregation phenomena.

  2024cites this paper
• Structural and functional changes caused by pathogenic variants in diabetes causing genes HNF1A and HNF1B

  2023cites this paper
• Characterization of a Panel of Monoclonal Antibodies Targeting the F-Protein of the Respiratory Syncytial Virus (RSV) for the Typing of Contemporary Circulating Strains

  2023cites this paper
• Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory Syncytial Virus Fusion Glycoprotein

  2022cites this paper
• Molecular modeling predicts novel antibody escape mutations in respiratory syncytial virus fusion glycoprotein

  2022cites this paper
• Heptad stereotypy, S/Q layering, and remote origin of the SARS-CoV-2 fusion core

  2021cites this paper
• Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion.

  2021cites this paper
• Drug resistance assessment following administration of RSV fusion inhibitor presatovir to participants experimentally infected with respiratory syncytial virus.

  2020cites this paper
• Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants

  2020influential citation
• Assessment of Drug Resistance during Phase 2b Clinical Trials of Presatovir in Adults Naturally Infected with Respiratory Syncytial Virus

  2020influential citation
• Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.

  2019cites this paper
• Liposomes: a promising carrier for respiratory syncytial virus therapeutics

  2019cites this paper
• Late activation of the Raf/MEK/ERK pathway is required for translocation of the respiratory syncytial virus F protein to the plasma membrane and efficient viral replication

  2018cites this paper
• Non-human papillomaviruses for gene delivery in vitro and in vivo

  2018cites this paper
• Sequence-dependent dynamical instability of the human prion protein: a comparative simulation study

  2018cites this paper
• Recent Advances in Developing Antiviral Therapies for Respiratory Syncytial Virus

  2017cites this paper
• Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery

  2017cites this paper
• The Heptad Repeat C Domain of the Respiratory Syncytial Virus Fusion Protein Plays a Key Role in Membrane Fusion

  2017cites this paper
• GENETIC AND ANTIGENIC CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS STRAINS ISOLATED IN ST. PETERSBURG IN 2013-2016.

  2017cites this paper
• Molecular mechanism of respiratory syncytial virus fusion inhibitors.

  2016cites this paper
• A generic screening platform for inhibitors of virus induced cell fusion using cellular electrical impedance

  2016cites this paper
• The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation

  2016cites this paper
• Cell fusion assay by expression of respiratory syncytial virus (RSV) fusion protein to analyze the mutation of palivizumab-resistant strains.

  2016cites this paper
• The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals.

  2015cites this paper
• Intranasal Administration of Maleic Anhydride-Modified Human Serum Albumin for Pre-Exposure Prophylaxis of Respiratory Syncytial Virus Infection

  2015cites this paper
• Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses

  2015cites this paper
• Discovery of imidazopyridine derivatives as highly potent respiratory syncytial virus fusion inhibitors.

  2015cites this paper
• Profilaksa infekcije respiratornim sincicijskim virusom s posebnim osvrtom na profilaksu u djece s prirođenim srčanim greškama

  2015cites this paper
• Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors

  2014cites this paper
• Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures

  2014cites this paper
• The N500 Glycan of the Respiratory Syncytial Virus F Protein is Required for Fusion, but Not for Stabilization or Triggering of the Protein

  2013influential citation
• RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function

  2013cites this paper
• The Respiratory Syncytial Virus Fusion Protein Targets to the Perimeter of Inclusion Bodies and Facilitates Filament Formation by a Cytoplasmic Tail-Dependent Mechanism

  2013cites this paper
• Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection

  2013cites this paper
• Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein

  2013influential citation
• The Human Respiratory Syncytial Virus Matrix Protein Is Required for Maturation of Viral Filaments

  2012cites this paper
• Purification of human respiratory syncytial virus fusion glycoprotein.

  2012cites this paper
• Targeting RSV with vaccines and small molecule drugs.

  2012cites this paper
• Modelagem Molecular da Interação entre a Proteína de Fusão do Vírus Sincicial Respiratório Humano e Inibidores da Ação Viral

  2012cites this paper
• Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion: A Focus on Respiratory Syncytial Virus

  2012cites this paper
• Discovery of the RSV Inhibitor TMC353121

  2011cites this paper
• Kinetic Investigations of Thiolate Protected Gold Nanoparticles: Protein Interactions, Electron Transfer, and Precursor Formation

  2011cites this paper
• Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processing

  2010cites this paper
• Séquences d'acides aminés améliorées dirigées contre le virus respiratoire syncytial (rsv) humain et polypeptides les comprenant pour la prévention et/ou le traitement des infections de l'appareil respiratoire

  2010cites this paper
• Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion

  2010cites this paper
• Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potency

  2010cites this paper
• Expression and characterization of a multivalent human respiratory syncytial virus protein

  2010cites this paper
• Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection.

  2009cites this paper
• Secondary RNA Structure and its Role in RNA Interference to Silence the Respiratory Syncytial Virus Fusion Protein Gene

  2009cites this paper
• Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus–induced inflammation and infection

  2009cites this paper
• Estudo de potenciais inibidores de infecção causada por Vírus Sincicial Respiratório em cultura de célula

  2009cites this paper
• Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus

  2008cites this paper
• Short Communication Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus

  2008cites this paper
• Expression and purification of human respiratory syncytial virus recombinant fusion protein.

  2008influential citation
• Review Article RNA Interference as A Potential Therapeutic Treatment for Inflammation Associated Lung Injury

  2008cites this paper
• RNA interference as a potential therapeutic treatment for inflammation associated lung injury.

  2008cites this paper
• Pneumovirus infection and effects on dendritic cells of mice

  2008cites this paper
• Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121).

  2008cites this paper
• Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps

  2007cites this paper
• development of phrophylactic strategies

  2006cites this paper
• Molecular Biology of Human Respiratory Syncytial Virus

  2006cites this paper
• A mutant fusion (F) protein of simian virus 5 induces hemagglutinin-neuraminidase-independent syncytium formation despite the internalization of the F protein.

  2006cites this paper
• Modular alpha-helical mimetics with antiviral activity against respiratory syncitial virus.

  2006cites this paper
• Biología molecular del virus sincitial respiratorio y desarrollo de estrategias profilácticas

  2006cites this paper
• Contribution of cysteine residues in the extracellular domain of the F protein of human respiratory syncytial virus to its function

  2006influential citation
• The cytoplasmic domain of the F protein of Human respiratory syncytial virus is not required for cell fusion.

  2006cites this paper
• Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein

  2005cites this paper
• Small Molecules VP-14637 and JNJ-2408068 Inhibit Respiratory Syncytial Virus Fusion by Similar Mechanisms

  2005cites this paper
• Role of the Simian Virus 5 Fusion Protein N-Terminal Coiled-Coil Domain in Folding and Promotion of Membrane Fusion

  2005cites this paper
• Inhibition of respiratory viruses by nasally administered siRNA

  2005cites this paper
• New drugs and treatment for respiratory syncytial virus

  2004cites this paper
• Virus entry: molecular mechanisms and biomedical applications

  2004cites this paper
• In search of a small-molecule inhibitor for respiratory syncytial virus

  2004cites this paper